SCHEMBL19080068

SCHEMBL19080068

c1ccc2c(-c3c4ccccc4c(-c4ccc5cc(-c6ccc7c(c6)c6ccccc6c6c7oc7ccc8ccccc8c76)ccc5c4)c4ccccc34)cccc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 3/20 0.35
CYP1B1 Q16678 1/20 0.35
ABCG2 Q9UNQ0 2/20 0.34
AHR P35869 3/20 0.34
PAX8 Q06710 2/20 0.34
CYP1A2 P05177 2/20 0.34
FYN P06241 1/20 0.34
MAPK3 P27361 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
MEN1 O00255 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 1/20 0.34
ARSA P15289 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079963 0.94 AHR (0.34) CYP1A1ABCG2AHRPAX8CYP1A2
SCHEMBL19080077 0.93 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2RAB9AMAPT
SCHEMBL19079974 0.92 AHR (0.37) CYP1A1ABCG2AHRPAX8CYP1A2
SCHEMBL19080106 0.92 CYP1A1 (0.41) CYP1A1CYP1B1ABCG2AHRPAX8
SCHEMBL19081656 0.91 ALOX5 (0.36) CYP1A1CYP1B1ABCG2AHRPAX8
SCHEMBL19080088 0.91 CYP1A1 (0.38) CYP1A1CYP1B1ABCG2AHRPAX8
SCHEMBL17944572 0.91 ALOX5 (0.38) CYP1A1CYP1B1TDP1MAPTARSA
SCHEMBL19080054 0.91 ALOX5 (0.37) CYP1A1ABCG2AHRPAX8CYP1A2
SCHEMBL17931984 0.91 ALOX5 (0.37) CYP1A1CYP1B1ABCG2AHRPAX8
SCHEMBL19080071 0.90 SOS1 (0.34) CYP1A1CYP1B1CYP1A2RAB9ACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1B1 225/4885ABCG2 4758/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1B1 225/4885ABCG2 4758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.